Аллергические болезни: диагностика и лечение - Паттерсон Р.
ISBN 5-9231-0011-8
Скачать (прямая ссылка):
1. Gulli SJ., Auslen K.R. Mast Cell and Basophil Differentiation in Health and Disease. - N.Y.: Raven Press, 1989.
2. Bernstein J.A., Lawrence I.D. The mast cell: a comprehensive, updated review // Allergy Proc. -
1990.-Vol. 11.-P. 209.
3. Irani A.A et al. Two types of human mast cells that have distinct neutral protease compositions // Proc. Natl. Acad. Sci. U. S. A. - 1986. - Vol. 83, No. 2. - P. 4464-4468.
4. Benyon R.C. et al. Dispersion and characterization of mast cells from human skin I I Int. Arch. Allergy Appl. Immunol. - 1986. - Vol. 79. - P. 332.
5. Fox C.C. et al. Isolation and characterization of human intestinal mucosal mast cells // J. Immunol.
- 1985.-Vol. 135.-P. 483.
6. Mikhail G.R., Miller-Milinska A. Mast cell population in human skin // J. Invest. Dermatol. - 1964. -Vol. 43.-P. 249.
7. Valeilt P. et al. Induction of differentiation of human mast cells from bone marrow and peripheral blood mononuclear cells by recombinant human stem cell factor/kit-ligand in long-term culture // Blood. - 1990. - Vol. 80. - P. 2237.
71
8. Galli S.J. et al. The c-kit receptor, stem cell factor, and mast cells: what each is teaching about the others // Am. J. Pathol. - 1993. - Vol. 142. - P. 965.
9. Thompson-Snipes L. et al. Interleukin-10: a novel stimulatory factor for mast cells and their progenitors 11 J. Exp. Med. - 1991. - Vol. 173. - P. 507.
10. Smith C.A., Rennick D.M. Characterization of a murine lymphokine distinct from interleukin-2 and interleukin-3 possessing a T-cell growth factor activity and a mast cell growth factor activity that synergizes with IL-3 // Proc. Natl. Acad. Sci. USA. - 1986. -Vol. 83. - P. 1857.
11. Broide DM. et al. TGF-B selectively inhibits IL-3-dependent mast cell proliferation without affecting mast cell function or differentiation // J. Immunol. - 1989. - Vol. 143. - P. 1591.
12. Dvorak A.M. The fine structure of human basophils and mast cells // Mast Cells, Mediators and Disease / Ed. S.T. Holgate. - Lond.: Kluwer Academic Publishers, 1988. - P. 29.
13. Coleman J.W. et al. Regulation of mouse peritoneal mast cell secretory function by stem cell factor. IL-3, IL-4 // J. Immunol. - 1993. - Vol. 150. - P. 556.
14. Alam R. et al. Comparative effect of recombinant IL-1, 2, 3, 4, and 6, IFN-gamma, granulocyte-macrophage colony stimulating factor, tumor necrosis factor-alpha, and histamine from basophils // J. Immunol. - 1989. - Vol. 142. - P. 3431.
15. MacDonald S.M'et al. Studies of IgE-dependent histamine releasing factors: heterogeneity of IgE // Ibid. - 1987. - Vol. 139. - P. 506.
16. Siriganian R.P. Mechanism of IgE-mediated hypersensitivity // Allergy: Principles and Practice / Eds. E. Middleton et al. - 4th ed. - St. Louis: Mosby, 1993.
17. Schwartz L.B. Mast cells: function and contents 11 Curr. Opin. Immunol. - 1994. - Vol. 6. - P. 91.
18. Paterson N.A.M. et al. Release of chemical mediators from partially purified human lung cells 11 J. Immunol. - 1976. - Vol. 117. - P. 1356.
19. MaeGlashan D.W., Lichtenslein L.M. The purification of human basophils // Ibid. - 1980. - Vol. 124.-P. 219.
20. Barnes P. et al. Nocturnal asthma and changes in circulating epinephrine, histamine, and cortisol
11 N. Engl. J. Med. - 1980. - Vol. 303. - P. 263.
21. Black J.W. et al. Definition and antagonism of histamine H2-receptors // Nature. - 1972. - Vol. 236. - P. 385.
22. Marquardt D.L. Histamine // Clin. Rev. Allergy. - 1983. - Vol. 1. - P. 343.
23. WestR.E. et al. Identification of two H3-histamine-receptor subtypes I I Mol. Pharmacol. - 1990. -Vol. 38.-P. 610.
24. O'Flaherty J.T., Wykie R.L. Biology and biochemistry of platelet-activating factor // Clin. Rev. Allergy. - 1983. - Vol. 1. - P. 353.
25. Wardlaw A. et al. Platelet activating factor: a potent chemotatic and chemokinetic factor for eosinophils // J. Clin. Invest. - 1986. - Vol. 78. - P. 1701.
26. Cuss F.M. et al. Effects of platelet activating factor on pulmonary function and bronchial responsiveness in man // Lancet. - 1986. - Vol. 2. - P. 189.
27. Hardy C.C. et al. The bronchoconstrictor effects of inhaled prostaglandin D2 in normal and asthmatic men 11 N. Engl. J. Med. - 1984. - Vol. 311. - P. 209.
28. Roberts LJ. et al. Increased production of prostaglandin D2 in patients with systemic mastocytosis // Ibid. - 1980. - Vol. 303. - P. 1400.
29. Murakami M. et al. IgE- dependent activation of cytokine primed mouse cultured mast cells induces a delayed phase of prostaglandin D2 generation via prostaglandin endoperoxidase synthase 2 // J. Immunol. - 1995. - Vol. 155. - P. 4445.
30. Israel E. et al. The effect of inhibition of 5-lipoxygenase by Zileuton in mild to moderate asthma // Ann. Intern. Med. - 1993. - Vol. 119. - P. 1059.
31. Lewis R.A. etal. Leukotrienes and the products of the 5-lipoxygenase pathway: biochemistry and relation to pathobiology in human diseases // N. Engl. J. Med. - 1990. - Vol. 323. - P. 645.
72
32. Henderson W.RJr. The role of leukotrienes in inflammation // Ann. Intern. Med. - 1994. - Vol.
